Danziten Inner Carton 71mg (Danziten 71mg Inner Carton Label)
This is not-available.*
Danziten Tablet
Product Images NDC 24338-155
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Danziten (NDC 24338-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Danziten Outer Carton 71mg (Danziten 71mg Outer Carton Label)
Danziten Inner Carton 95mg (Danziten 95mg Inner Carton Label)
This is a pharmaceutical label for "Danziten" tablets containing nilotinib. The label provides information on the dosage, storage conditions, and the manufacturer's details. It includes instructions to dispense with the medication guide, details the content of each pack, and specifies the storage temperature range. The medication is in tablet form with a dosage strength of 95 mg. The text also mentions keeping the tablets away from moisture and heat.*
Danziten Outer Carton 95mg (Danziten 95mg Outer Carton Label)
Danziten Structure (Danziten Structure)
Figure-1 (Figure 1)
Figure-2 (Figure 2)
This is a statistical table showing data related to treatment-free survival percentage and time since therapy discontinuation. The table includes information on the number of events at different time points, censoring observations, and the number of at-risk individuals at each time interval. The data presents a snapshot of survival percentages at various weeks post-treatment cessation.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
